ResultsIQ

ResultsIQ › Latest results › Gem Aromatics Limited

Gem Aromatics Limited Q4 FY26 results deck summary

NSE: GEMAROMA · BSE: 544491

Results deck of 21 May 2026, summarised by AI from the filing.

No forward-looking guidance was provided in the presentation.

Key takeaways

  1. Guidance No forward-looking guidance was provided in the presentation.
  2. Growth driver Commercial production of GEM Cool 5 and Safranal commenced on 26 February 2026, completing the integrated portfolio across cooling agents, Safranal, Clove Oil, Eugenol and clove derivatives.
  3. Risk Availability of key petrochemical raw materials such as phenol impacted, leading to significant price volatility and a sharp increase in raw material prices.

Original filing on BSE

Gem Aromatics Limited Q1 FY27 results

As filed: Revenue ₹98.9 cr (+12% year on year), EBITDA ₹3.3 cr (−79% year on year), PAT −₹7.9 cr (−198% year on year), EBITDA margin 3.4% (−1,000 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹112 cr, EBITDA ₹15.1 cr, PAT ₹11.9 cr, EBITDA margin 13.4%. Not scored. No result for the same quarter last year. Share price after the results: +10.9% in 29 days (Nifty 500: +2.4%).
  • Q3 FY26: Revenue ₹83.9 cr, EBITDA ₹7.6 cr, PAT ₹4.2 cr, EBITDA margin 9.1%. Not scored. No result for the same quarter last year. Share price after the results: +28.9% in 30 days (Nifty 500: +2.8%).
  • Q2 FY26: Revenue ₹98.0 cr, EBITDA ₹5.0 cr, PAT ₹4.0 cr, EBITDA margin 5.1%. Not scored. No result for the same quarter last year. Share price after the results: −28.9% in 29 days (Nifty 500: −0.4%).
  • Q1 FY26: Revenue ₹76.0 cr, EBITDA ₹10.0 cr, PAT ₹7.0 cr, EBITDA margin 13.2%. Not scored. No result for the same quarter last year. Share price after the results: −13.1% in 28 days (Nifty 500: +0.6%).

Past price moves after results do not indicate future moves. Not a recommendation.

Gem Aromatics Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.